Mira Fertility Monitor Drops Ad Claims After P&G Challenge
Quanovate Tech pulled marketing claims for its Mira Fertility Monitor after P&G filed a National Advertising Division challenge.
Quanovate Tech just blinked. The maker of the Mira Fertility Monitor and Test Wands voluntarily pulled its advertising claims after Procter & Gamble took the fight to the BBB National Programs' National Advertising Division (NAD). No court battle needed — just a formal challenge and Quanovate walked its claims back.
The NAD is the ad industry's self-regulatory referee. When a competitor files a challenge there, the pressure is real. Companies that ignore rulings risk referral to the FTC. Quanovate chose the smarter exit — discontinuing the disputed claims rather than defending them through a full review.
Read more Kodak Lab Locator Tool Sits Behind a Paywall →
For P&G, this is a strategic win in the competitive fertility-tracking market. The consumer goods giant clearly believes Mira's messaging crossed a line, and the NAD process gave it a low-cost, high-impact way to police that space. No lawsuit, no discovery, just results.
If you're a consumer shopping for fertility monitors, take note: when a company pulls its own claims under regulatory pressure, that's a signal worth paying attention to. What exactly was being said about Mira's accuracy or capabilities? The voluntary discontinuation leaves that question hanging — but the move itself speaks volumes.
Continue reading at GlobalNewswire.
